TruDiagnostic
Quick facts
Phase 3 pipeline
- SARS-CoV-2 mRNA vaccine · Immunology
The SARS-CoV-2 mRNA vaccine works by instructing cells to produce a piece of the SARS-CoV-2 virus, triggering an immune response to fight the virus.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: